Food and Drug Administration
March 3, 2005
Slides
FDA Introduction, Dr. Malcolm Moos, Jr. (HTM) (PPT)
FDA Perspective on the Development of Cellular Therapies for Repair and Regeneration of Joint Surfaces - Preclinical Perspective, Dr. Richard McFarland, PhD, MD (HTM) (PPT)
Preclinical Animal Models of Cartilage Repair and Regeneration, Dr. Matthew Allen, Vet. MB, PhD, SUNNY Upstate Medical University (HTM) (PPT)
FDA Perspective on the Development of Cellular Therapies for Repair and Regeneration of Joint Surfaces - Clinical, Dr. Susan Leibenhaut (HTM) (PPT)
Perspectives on Clinical Outcomes of Studies of Products for Use in Cartilage Repair, Dr. Marc Hochberg, MD, MPH, University of MD School of Medicine (HTM) (PPT)